User menu

Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal γδ T-cell number: a prospective case-series study

Bibliographic reference Buysschaert, Martin ; Baeck, Marie ; Preumont, Vanessa ; Marot, Liliane ; Hendrickx, Emilie ; et. al. Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal γδ T-cell number: a prospective case-series study. In: British Journal of Dermatology, Vol. 171, no. 1, p. 155-161 (2014)
Permanent URL
  1. Schön Michael P., Boehncke W.-Henning, Psoriasis, 10.1056/nejmra041320
  2. Nestle Frank O., Kaplan Daniel H., Barker Jonathan, Psoriasis, 10.1056/nejmra0804595
  3. Waite Janelle C., Skokos Dimitris, Th17 Response and Inflammatory Autoimmune Diseases, 10.1155/2012/819467
  4. Kanai Y, Satoh T, Igawa K, Yokozeki H, Impaired Expression of Tim-3 on Th17 and Th1 Cells in Psoriasis, 10.2340/00015555-1285
  5. Cai Yihua, Fleming Chris, Yan Jun, Dermal γδ T cells — A new player in the pathogenesis of psoriasis, 10.1016/j.intimp.2013.02.018
  6. Sommer Dorothea M., Jenisch Stefan, Suchan Michael, Christophers Enno, Weichenthal Michael, Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis, 10.1007/s00403-006-0703-z
  7. Gisondi P., Tessari G., Conti A., Piaserico S., Schianchi S., Peserico A., Giannetti A., Girolomoni G., Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study, 10.1111/j.1365-2133.2007.07986.x
  8. Armstrong A W, Harskamp C T, Armstrong E J, The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies, 10.1038/nutd.2012.26
  9. Gottlieb Alice B., Dann Frank, Comorbidities in Patients with Psoriasis, 10.1016/j.amjmed.2009.06.021
  10. Li Wenqing, Han Jiali, Hu Frank B., Curhan Gary C., Qureshi Abrar A., Psoriasis and Risk of Type 2 Diabetes among Women and Men in the United States: A Population-Based Cohort Study, 10.1038/jid.2011.319
  11. Azfar Rahat S., Seminara Nicole M., Shin Daniel B., Troxel Andrea B., Margolis David J., Gelfand Joel M., Increased Risk of Diabetes Mellitus and Likelihood of Receiving Diabetes Mellitus Treatment in Patients With Psoriasis, 10.1001/archdermatol.2012.1401
  12. Xu, Eur J Dermatol, 22, 396 (2012)
  13. Buysschaert M., Preumont V., Oriot P.R., Paris I., Ponchon M., Scarnière D., Selvais P., One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice, 10.1016/j.diabet.2010.03.009
  14. Preumont V., Hermans M.-P., Brichard S., Buysschaert M., Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivity, 10.1016/j.diabet.2010.02.001
  15. Drucker Daniel J., The biology of incretin hormones, 10.1016/j.cmet.2006.01.004
  16. Ahern T., Tobin A.-M., Corrigan M., Hogan A., Sweeney C., Kirby B., O’Shea D., Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study : GLP-1 analogue therapy for psoriasis, 10.1111/j.1468-3083.2012.04609.x
  17. Buysschaert M., Tennstedt D., Preumont V., Improvement of psoriasis during exenatide treatment in a patient with diabetes, 10.1016/j.diabet.2011.11.004
  18. Faurschou A., Knop F. K., Thyssen J. P., Zachariae C., Skov L., Vilsbøll T., Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide, 10.1007/s00592-011-0359-9
  19. Hogan A. E., Tobin A. M., Ahern T., Corrigan M. A., Gaoatswe G., Jackson R., O’Reilly V., Lynch L., Doherty D. G., Moynagh P. N., Kirby B., O’Connell J., O’Shea D., Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis, 10.1007/s00125-011-2232-3
  20. Puzenat E, Bronsard V, Prey S, Gourraud P-A, Aractingi S, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Paul C, Richard-Lallemand M-A, Ortonne J-P, Aubin F, What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature, 10.1111/j.1468-3083.2009.03562.x
  21. Hanas R., John G., , 2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1c Measurement, 10.1373/clinchem.2010.150540
  22. Baeck Marie, Soria Angèle, Marot Liliane, Theate Ivan, Hendrickx Emilie, Van Belle Astrid, Goossens An, Tennstedt Dominique, Dachelet Claire, Jaeger Johnathan, Pilette Charles, Renauld Jean-Christophe, Van Baren Nicolas, Rozières Aurore, Nicolas Jean-Fançois, Dumoutier Laure, Characterization of the T cell response in allergic contact dermatitis caused by corticosteroids, 10.1111/cod.12040
  23. Chaudhuri Ajay, Ghanim Husam, Vora Mehul, Sia Chang Ling, Korzeniewski Kelly, Dhindsa Sandeep, Makdissi Antoine, Dandona Paresh, Exenatide Exerts a Potent Antiinflammatory Effect, 10.1210/jc.2011-1508
  24. Drucker D. J., Rosen C. F., Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology, 10.1007/s00125-011-2297-z
  25. Laggner U., Di Meglio P., Perera G. K., Hundhausen C., Lacy K. E., Ali N., Smith C. H., Hayday A. C., Nickoloff B. J., Nestle F. O., Identification of a Novel Proinflammatory Human Skin-Homing V 9V 2 T Cell Subset with a Potential Role in Psoriasis, 10.4049/jimmunol.1100804
  26. Becher Burkhard, Pantelyushin Stanislav, Hiding under the skin: Interleukin-17–producing γδ T cells go under the skin?, 10.1038/nm.3016
  27. Faurschou Annesofie, Zachariae Claus, Skov Lone, Vilsbøll Tina, Knop Filip K., Gastric bypass surgery: Improving psoriasis through a GLP-1-dependent mechanism?, 10.1016/j.mehy.2011.09.011
  28. Hossler Eric W., Maroon Michele S., Mowad Chris M., Gastric bypass surgery improves psoriasis, 10.1016/j.jaad.2010.01.001
  29. Hossler E.W., Wood G.C., Still C.D., Mowad C.M., Maroon M.S., The effect of weight loss surgery on the severity of psoriasis : Correspondence, 10.1111/j.1365-2133.2012.11211.x
  30. Laferrère B., Effect of gastric bypass surgery on the incretins, 10.1016/s1262-3636(09)73458-5
  31. Makdissi Antoine, Ghanim Husam, Vora Mehul, Green Kelly, Abuaysheh Sanaa, Chaudhuri Ajay, Dhindsa Sandeep, Dandona Paresh, Sitagliptin Exerts an Antinflammatory Action, 10.1210/jc.2012-1544
  32. Nishioka Tatsuya, Shinohara Masayuki, Tanimoto Noriyasu, Kumagai Chizuru, Hashimoto Kozo, Sitagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Psoriasis, 10.1159/000333358